bimekizumab,adalimumab
ucb pharmaceuticals,abbvie
[' psa', 'bimekizumab']
#spa posters #acr22 2117. bimekizumab improvements in efficacy on disease activity assessed via composite endpoints in bdmard-na ve &amp; tnfi-ir pas w psa pooled 16w ph3 rct improvements in overall disease activity irrespective of prior bdmard use #acrambassador 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books